Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

China · Delayed Price · Currency is CNY

14.25

-0.19 (-1.32%)

Apr 8, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
API Division	1.03B	1.26B	1.68B	2.06B	-
API Division Growth	-17.98%	-25.17%	-18.61%	-	-
Formulation Division	369.81M	325.49M	400.16M	483.26M	-
Formulation Division Growth	13.62%	-18.66%	-17.20%	-	-
Radio Pharmaceutical Division	1.13B	1.01B	1.02B	914.90M	-
Radio Pharmaceutical Division Growth	11.50%	-0.52%	11.20%	-	-
Others	281.40M	275.98M	180.60M	123.77M	-
Others Growth	1.96%	52.81%	45.92%	-	-
Offset of Business Segment	-68.19M	-	-	-	-
Pharmaceutical Industry	-	-	-	-	3.91B
Pharmaceutical Industry Growth	-	-	-	-	14.42%
Total	2.74B	2.87B	3.28B	3.58B	3.91B
Total Growth	-4.46%	-12.42%	-8.58%	-8.41%	14.42%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	1.62B	1.56B	1.64B	1.53B	1.75B
China Growth	3.85%	-4.85%	7.21%	-12.53%	-
Overseas	1.12B	1.31B	1.63B	2.05B	2.16B
Overseas Growth	-14.41%	-20.03%	-20.38%	-5.07%	-
Total	2.74B	2.87B	3.28B	3.58B	3.91B
Total Growth	-4.46%	-12.42%	-8.58%	-8.41%	-

Source: S&P Global Market Intelligence.